Small and large cap stocks are widely popular for a variety of reasons, however, mid-cap companies such as BTG plc ( LON:BTG ), with a market cap of UK£2.01b, often get neglected by retail investors.

Boston Scientific Corp. BSX 0.67% has agreed to buy British health-care firm BTG PLC for £3.3 billion ($4.24 billion), bolstering its presence in the growing field of interventional medicine ...

Banco BTG Pactual SA, Latin America’s largest independent investment bank, agreed to buy HSBC Holdings Plc’s operations in ...

To bolster its offerings in interventional medicine, Boston Scientific agreed to purchase British device and pharma firm BTG PLC. for $4.24 billion in cash, according to The Wall Street Journal.

LONDON, July 16, 2019 /PRNewswire/ -- BTG International Asia Limited, a subsidiary of BTG plc (LSE: BTG) announced today that it has agreed to invest RMB 76million (approximately USD 11million) in ...

A U.S. unit of British drug company BTG Plc pleaded guilty on Monday to improperly marketing its embolic device LC Bead, and will pay about $36 million to resolve its criminal and civil liability ...

Boston Scientific Corp. BSX said Tuesday that it has agreed to a takeover bid for U.K. specialty health-care company BTG PLC (BTG.LN) in a deal worth 3.3 billion pounds ($4.23 billion). The ...

BTG plc (LSE: BTG), the global specialist healthcare company, today announces it has acquired Novate Medical Ltd. (“Novate”), a medical device company ...

BTG plc is a UK pharmaceutical company specializing in antivenoms, oncology drugs and treatments for varicose veins. BTG's snakebite antivenom, Crofab, has been the most significant contributor to ...

Shares of BTG PLC (BTG.LN) fell in early trade Friday after the health-care company said that a U.S. Food & Drug Administration panel has voted against the approval of its Elevair Endobronchial ...

British biotech firm BTG Plc <BGC.L> said on Friday initial trial results show its Varisolve varicose vein treatment is safe for use in patients with a common heart defect, and it is looking ...

Galil Medical Inc., a developer of cryoablation products for the treatment of kidney and other cancers, has agreed to be acquired by specialist health-care company BTG PLC. BTG will pay $84.5 ...